BACKGROUND: Pediatric obesity continues to rise and has become a major health problem worldwide. Vitamin D deficiency has been increasing among obese non-Asian children and is associated with abnormal glucose homeostasis in obese adults. However, data on the vitamin D status and its association with glucose homeostasis in obese children residing in tropical Asian countries are unavailable. OBJECTIVE: To assess vitamin D status and glucose homeostasis in obese Thai children. PATIENTS AND METHODS: A total of 150 obese, and 29 healthy non-obese children and adolescents were enrolled. Weight, height, body mass index (BMI) and waist circumference were obtained. All obese children underwent an oral glucose tolerance test with glucose and insulin measurements. Plasma 25-hydroxyvitamin D (25-OHD) and calciotropic blood chemistries were measured in all participants. Insulin sensitivity indices were calculated from the measured glucose and insulin levels. RESULTS: Approximately 25% of the obese children and adolescents had impaired glucose tolerance, impaired fasting plasma glucose (FPG) and diabetes. Seventeen out of 150 (11.3%) obese children and 3 out of 29 (10.3%) non-obese children had vitamin D deficiency, which was defined as a 25-OHD level of o50 nmol l À1 . Glucose tolerance and insulin sensitivity indices were comparable between obese children with sufficient vitamin D and those with vitamin D deficiency. There were no relationships among serum 25-OHD; weight, height, and BMI standard deviation scores; insulin sensitivity indices; FPG and insulin; and 2-h plasma glucose and insulin levels. CONCLUSION: Vitamin D deficiency is not as prevalent in obese Thai children as in obese non-Asian children from highlatitude countries. Adiposity per se is unlikely to be a determinant of vitamin D status in these obese individuals. There was no association between vitamin D deficiency and abnormal glucose homeostasis.
INTRODUCTION
Pediatric obesity is on the rise worldwide and has become a major health problem. 1, 2 Obesity-related metabolic complications in children, including abnormal glucose homeostasis (that is, insulin resistance, impaired glucose tolerance and type 2 diabetes), hypertension, dyslipidemia and metabolic syndrome, are increasing in prevalence. 1 --5 Increased adiposity has been associated with low levels of circulating 25-hydroxyvitamin D (25-OHD), the determinant of vitamin D status. 6, 7 In addition, a high prevalence of vitamin D deficiency has been reported in obese adults and children. 8 --12 Vitamin D has a well-known effect on bone metabolism and calcium homeostasis. Moreover, vitamin D deficiency has been linked to a wide range of chronic diseases, such as diabetes mellitus, hypertension, cancer and autoimmune diseases. 13, 14 In adults, vitamin D deficiency has been proposed to be a risk factor for the development of glucose intolerance and type 2 diabetes because it reduces insulin secretion and sensitivity. 15 --17 Therefore, vitamin D deficiency in obese individuals who are already at high risk of developing metabolic complications may aggravate those complications.
Obese children and adolescents are at particular risk for longterm metabolic complications. If a low vitamin D level has a detrimental effect on glucose homeostasis, obese children and adolescents who are vitamin D deficient would be at a particularly high risk for the early development of abnormal glucose homeostasis and type 2 diabetes.
Vitamin D is primarily synthesized by the skin following sun exposure and is partly derived from dietary sources. 18 Low sun exposure is an important risk factor of vitamin D deficiency. 18, 19 Therefore, individuals who have dark skin, wear concealing clothing and/or reside at high latitudes or in countries with low levels of sun exposure are at an increased risk for vitamin D deficiency. Most studies involving the high prevalence of vitamin D deficiency in obese individuals have been conducted in highlatitude countries, Caucasian, and Hispanic and African --American ethnic groups. 8 --12,20,21 However, no data on the vitamin D status and its association with glucose homeostasis of obese children and adolescents living in tropical Asian countries are currently available.
We hypothesized that vitamin D deficiency would not frequently occur in obese children and adolescents who live in tropical countries. Thus, obesity may not be a critical factor affecting vitamin D status in obese children and adolescents residing at tropical latitudes.
PATIENTS AND METHODS Patients
This cross-sectional study enrolled 150 exogenously overweight or obese Thai children and adolescents. Overweight and obesity were defined according to the World Health Organization body mass index classification. 22 All children and adolescents were Thais of Asian origin who did not wear concealing clothing or have dark skin. The study was undertaken at Ramathibodi Hospital (a teaching hospital), Mahidol University, Bangkok, Thailand (latitude 131N), between February 2008 and June 2009. Exclusion criteria were a diagnosis of syndromic obesity, chronic illnesses or bone diseases, and the use of diuretics, systemic glucocorticoids or medications that affect glucose, calcium or phosphate metabolism. Twenty-nine nonobese, healthy children served as controls. The 'obese' participants were recruited from the pediatric outpatient clinic of Ramathibodi Hospital. These patients presented with either simple acute illness (such as upper respiratory tract infection or skin problems) or obesity itself as their chief complaint. The 'control' participants were children with normal growth and development who had been followed at our pediatric growth clinic. The study was approved by the Ethics Committee, Ramathibodi Hospital, Mahidol University. Informed consent was obtained from the legal guardians of all participants. Each patient's consent was also obtained.
Methods
Anthropometric data, including weight, height and BMI, were recorded from all participants, but waist circumference was only measured in obese children. Standard deviation scores (SDSs) of weight and height were calculated using the National Standard Growth Curve of the Ministry of Public Health, Thailand. 23 BMI SDS was calculated using World Health Organization BMI standards. 22 The genital stage in males, and breast stage in females were assessed using the method of Marshall and Tanner. 24, 25 The waist circumference percentile was determined according to Fernández et al. 26 All children (when attending school) wore a student uniform with a short-sleeved shirt and short trousers or skirt. Their sunlight exposure history was ascertained using a specific question, 'Is the subject exposed to a 10 --30-min period of sunlight at least twice a week?' Sun exposure for at least 10 --30 min per day twice a week is considered adequate for vitamin D synthesis. 13 All overweight and obese individuals underwent an oral glucose tolerance test (OGTT). The fasting serum lipid profile, including total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides; calcium; phosphorus; magnesium; 25-OHD; and plasma intact parathyroid hormone (iPTH) levels were obtained in the obese children. All 29 control children had their fasting blood samples measured for glucose, insulin, calcium, phosphorus, magnesium, 25-OHD and iPTH. The blood samples were kept at À20 1C until the 25-OHD and iPTH analyses. Other blood chemistries were analyzed on the day of collection. Serum 25-OHD was measured by high-performance liquid chromatography (ClinRep complete kit for 25-hydroxyvitamin D2/D3 in plasma and serum, Recipe Chemicals and Instruments GmbH, Munich, Germany) with an intra-assay precision of 4.8% for 25-OHD2 and 4.9% for 25-OHD3. Plasma iPTH was measured by electrochemiluminescence immunoassay on a Cobas e411 (Roche Diagnostics GmbH, Mannheim, Germany). The assay had an intra-assay precision of 2.4%.
Oral glucose tolerance test
OGTT was performed in the morning between 0800 and 0900 hrs. After an overnight 12-h fast, blood samples were collected for glucose and insulin measurements. A standard flavoured glucose solution, with a dose of 1.75 g kg À1 of body weight (maximum 75 g), was then given orally over 5 min. Plasma glucose and insulin were measured at 30, 60, 90 and 120 min after glucose solution ingestion.
Insulin sensitivity assessment
The homeostatic model assessment of insulin resistance (HOMA-IR) 27 and whole-body insulin sensitivity index (WBISI) 28 were used to determine insulin sensitivity. HOMA-IR and WBISI were calculated using the following equations: The clinical data from patients with vitamin D sufficiency and those with vitamin D deficiency were compared. There were no differences in weight, height, BMI, waist circumference, iPTH level or OGTT results between the two groups ( Table 3 ). The type 2 diabetic patients were all vitamin D sufficient. The HOMA-IR and WBISI results were comparable between the two groups (Table 3) .
Age-, sex-, puberty-and BMI SDS-matched obese children with vitamin D deficiency and those with vitamin D sufficiency also showed no difference in performance on the OGTT (data not shown).
Pearson's correlation coefficient analyses revealed no relationship between serum 25-OHD and weight SDS (r ¼ À0. , residing at latitude 331N. 10 Lenders et al.
32
reported a prevalence of vitamin D deficiency of 29% in obese adolescents (age 14.9 ± 1.4 years and BMI 36 ± 5 kg m
À2
). Alemzadeh et al.
12 also reported vitamin D deficiency at a prevalence of 32% in their obese pediatric cohort, with an age of 13 ± 3 years and a BMI of 36.4 ± 8.1 kg m
. Vitamin-D-rich foods, such as fatty fish, are not staples of the diet of Thai children. In addition, the dairy products available in our country are not generally vitamin D fortified. Vegetable sources of vitamin D are negligible, as demonstrated by the undetectable levels of 25-OHD2 in almost all children examined here (data not shown). Therefore, food is not likely to be the major source of vitamin D for Thai children. Regarding the duration of exposure to sunlight, most of our children had a regular 1 --1.5-h daily outdoor physical education class at school, during which they were exposed to sunlight. Therefore, children residing in Thailand, a country that is relatively sunny year-round, are more likely to have adequate sunlight exposure than the children from high-latitude countries examined in other studies. In addition, our patients were all Asians and had light-brown skin. The presence of adequate sunlight exposure and light-brown skin in our study group could have contributed to the infrequency of vitamin D deficiency found in our obese children and adolescents.
Our obese children and adolescents had a lower BMI and were younger than those in the aforementioned studies, which caused some difficulty in comparing the degrees of obesity among these studies. However, being obese, with a mean BMI SDS of 3, seemed to have no demonstrable adverse effect on vitamin D status in our obese children and adolescents. If obesity directly affects the vitamin D level, the less severe degree of obesity in our patient group might not have been enough to alter vitamin D status and thus may have resulted in the relatively low frequency of vitamin Vitamin D and glucose homeostasis in obesity P Poomthavorn et al D deficiency observed. In addition, the frequency of vitamin D deficiency in our 29 non-obese healthy children and adolescents was 10.3%, which was similar to that in our obese patients. This further supports the idea that obesity per se is unlikely to negatively influence vitamin D status in obese children and adolescents. Moreover, our study did not show a negative correlation between serum 25-OHD level and waist circumference, an index of abdominal obesity. Taken together, these findings support the hypothesis that vitamin D status was not adversely affected by obesity in our patients. In regard to the relationships between vitamin D status and metabolic complications, this study did not find any differences in anthropometric data, glucose tolerance or insulin sensitivity indices between patients with and without vitamin D sufficiency. In addition, no correlations between 25-OHD level and weight SDS, height SDS, BMI SDS or insulin sensitivity indices were demonstrated. These data contrast with those from previous studies that showed greater metabolic complications in obese individuals with vitamin D deficiency. 9, 11, 21 A previous study 10 showed that a 25-OHD level of 37.5 nmol l À1 or less had a negative effect on insulin sensitivity, whereas a level of 37.5 --50.0 nmol l À1 had no such effect. Our study had a low frequency of vitamin D deficiency, which was defined based on a traditional 25-OHD level cutoff value of 50 nmol l
À1
, and only three patients had a 25-OHD level of o37.5 nmol l
; no patients had a 25-OHD level of o25 nmol l À1 .
As there was such a low frequency of vitamin D deficiency in our patients, the negative effects of vitamin D deficiency, if any, on insulin sensitivity and obesity-related metabolic complications were not easily demonstrated. However, our results are in agreement with a study that was conducted in Asian --Indian adults, which demonstrated a high prevalence of vitamin D insufficiency (25-OHD level o50 nmol l À1 ), but no association between vitamin D insufficiency and insulin resistance. 33 In contrast to the inverse relationship between plasma iPTH and insulin sensitivity demonstrated in a previous study, 34 our study did not find such a relationship. As the iPTH level has an inverse correlation with the 25-OHD level, the lack of an association between iPTH level and insulin sensitivity in our study may have been indirectly due to the lack of association between 25-OHD level and insulin sensitivity.
Our study included a significant number of overweight and obese children, and adolescents who were tested for glucose homeostasis by an OGTT. Approximately 80% of the obese children and adolescents in this study exhibited abnormal glucose homeostasis, which ranged from a normal plasma glucose level combined with hyperinsulinemia, to impaired FPG only, to impaired glucose tolerance, and finally to diabetes mellitus. Compared with previous studies 35 --37 performed in obese Greek and Italian children and adolescents, which showed a prevalence of glucose intolerance of 11 --15%, our patients demonstrated a greater proportion of abnormal glucose homeostasis: 19.3% had impaired glucose tolerance, 2.7% had impaired FPG and 3.3% had diabetes. Sinha et al. 38 reported similar rates of impaired glucose tolerance in B20 --25% and diabetes in 4% of markedly obese non-Hispanic white and black, and Hispanic children and adolescents, aged 4 --18 years, although these patients were more obese than our patients (BMI 30 --37 vs 28.6 kg m À2 ). A report from a hospital-based UK cohort showed that 10% of obese children (mean BMI of 33 kg m À2 ) had impaired glucose tolerance. 39, 40 As Asians, our overweight and obese children, and adolescents are at particularly high risk for developing metabolic complications such as type 2 diabetes, impaired glucose tolerance and dyslipidemia at a younger age and at lower levels of obesity. 41, 42 At present, in Asian populations, there is a trend towards increasing consumption of high-fat and high-sugar foods, as well as towards an increasingly sedentary lifestyle with less energy expenditure. This significant shift in dietary and physical activity patterns might account for the higher rate of abnormal glucose homeostasis found in these populations. 43, 44 These factors have detrimental effects on body composition, resulting in increased abdominal adiposity and ectopic fat deposition, which are important risk factors for abnormal glucose homeostasis. 43 Our study has some limitations. First, the degree of adiposity was not directly assessed in our study. BMI and waist circumference may not truly reflect body fat status. 45 Therefore, the findings of this study may not truly correlate with the degree of adiposity. Second, the obese individuals who were enrolled in this study did not represent a community-based population, as they were recruited from tertiary hospital visits. Some individuals presented with obesity and were concerned with obesity-related complications. Some of them were referred for specific obesity management. This selection bias may have caused the high percentage of abnormal glucose homeostasis found in this study. Third, the frequency of vitamin D deficiency in our study was low. Therefore, an association between vitamin D deficiency and abnormal glucose homeostasis, if present, may have been missed. A larger study population is required.
In conclusion, the majority of obese children in a sample from Thailand, a tropical country, had adequate vitamin D status. Despite having less severe obesity and a lower frequency of vitamin D deficiency (B11%), the frequency of abnormal glucose homeostasis was relatively high in our obese patients. These data suggest that vitamin D deficiency per se is not a major factor associated with abnormal glucose homeostasis in obese Thai children.
